Over- or underexpression of target lncRNA that regulate the phosphorylation of STAT3 significantly inhibited the proliferation of NSCLC cells and reversed the resistance of afatinib to NSCLC cells [64,65]. Here, STAT3 is linked to non-small cell lung carcinoma.